Expérience
Clinique de radiologie de l'hôpital Liman
Centre Médical de l'Académie
Centre Médical Anaclinique
Hôpital d'État de Kayseri
Clinique de radiologie universitaire Kayseri Erciyes
Centre médical privé Midiliv de Samsun
Hôpital Samsun Büyük Anadolu (2023)
Naphat Sirinimnualkul, M.D. (Dr. Ken), is a psychiatrist and clinical instructor at the Excellence Center for Sleep Disorders, King Chulalongkorn Memorial Hospital (2022–present). He previously served as a psychiatrist and clinical instructor at the General Police Hospital (Aug–Dec 2021). He completed his psychiatry residency at Chulalongkorn University (2018–2021).
Board/education: Diploma, Board of General Psychiatry, Thai General Medical Council (2018–2021). Graduate Diploma in Clinical Sciences (Psychiatry), Chulalongkorn University (2018–2021). M.D., Second Class Honors, Chulalongkorn University (2011–2017). Training: Cognitive Behavioral Therapy for Insomnia.
Expertise: sleep medicine, neuropsychiatry, consultation-liaison psychiatry, and psychopharmacology. He focuses on the interface between sleep and mood disorders.
Dr. Tara Rak-areekul is a neurologist focused on cognitive neurology. She is a fellow at King Chulalongkorn Memorial Hospital. She completed her neurology residency there and served as Chief of Academic in 2023. She holds an MD from Chulalongkorn University (Second Class Honors) and a Higher Graduate Diploma in Clinical Sciences. She is certified in NIHSS (2022) and the Thai Stroke Society Acute Stroke Treatment Course.
Key achievements include first rank in the National Formative Neurological Exam (2023). She won the Epilepsy Quiz Tournament (2023). She was first runner-up at the Neurology Tournaments at NST Midyear 2023 and the Chula Neuroscience Forum 2022. Her research includes AAIC poster presentations (2024, 2025). Ongoing work covers Alzheimer’s biomarkers (MDS‑OAβ and p‑tau217), the Thai clinical adaptation of HippoCamera, and a chapter on behavioral and psychological symptoms of dementia (BPSD).
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Spécialisations
Radiologie de l'abdomen
Radiologie Doppler
Radiologie obstétricale
Radiologie du sein
Radiologie musculo-squelettique
Radiologie pédiatrique
Neuroradiologie
Procédures interventionnelles non vasculaires
Somjet Tosamran, MD, is a neurologist. Dr. Tosamran is a fellow in epilepsy at the Neurology Division, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand (2024–present). Dr. Tosamran completed a neurology residency at the same hospital (2021–2024). Earlier training includes internships at Charoenkrung Pracharak Hospital and Sakaeo Crown Prince Hospital.
Accreditations and education: Neurologist certification, King Chulalongkorn Memorial Hospital (2024). Master of Science in Internal Medicine, Faculty of Medicine, Chulalongkorn University (2024). Doctor of Medicine, First Class Honors, Faculty of Medicine, Chulalongkorn University (2018).
Dr. Shady Mohammed El‑sebai is an interventional radiologist and diagnostic imaging consultant. He is the Consultant and Chief of Interventional Radiology at Sheaf El Orman Oncology Hospital (2021–present). He is also Chief of the Interventional Radiology Unit at the National Cancer Institute, Cairo University (2022–present). He has been a Lecturer in interventional radiology at the National Cancer Institute since 2018. Earlier posts include assistant lecturer and specialist, radiology resident, specialist at Khartoum Breast Care Centre, and specialist and consultant at Techno Scan.
Expertise includes CT‑ and US‑guided true‑cut biopsies and FNAC; transarterial chemoembolization for HCC and for liver, renal, and soft‑tissue tumors; percutaneous nephrostomy and ureteric stents; pigtail drainage; and RF or microwave ablation of hepatic, bone, lung, and thyroid lesions. He also performs PTD and biliary stents; uterine artery embolization; coiling for pelvic varicosities and varicocele; varicose vein ablation and sclerotherapy; and breast procedures (biopsy, markers, wire localization, Mammotome). He is skilled in US, CT, and MRI.
Dr. Alper Karaoglan is a Professor of Neurosurgery at Memorial Bodrum Hospital. He has many years of experience in neurosurgery. He worked at Maltepe University Faculty of Medicine and Taksim Training and Research Hospital in Istanbul. Since 2008, he has held the positions of Professor, Associate Professor, and Assistant Professor in neurosurgery.
Dr. Karaoglan is a member of the Turkish Medical Association and the Turkish Neurosurgical Society. He has received several awards. These include the Best Paper Award at the Turkish Neurosurgical Society Scientific Congress in 2005 for his research on resveratrol’s protective effects after subarachnoid hemorrhage, and the Young Neurosurgeon Encouragement Award in 2008.
Oui
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.
Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.
Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.
Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.
Op. Dr. Tansu Gürsoy is a brain and nerve surgery specialist at Çerkezköy Private Optimed Hospital. He completed his training at Ankara Training and Research Hospital. His practice focuses on spine surgery. Key areas include degenerative scoliosis, herniated discs, spinal stenosis, trauma, and tumors.
In 2019, he won third place from the Turkish Neurosurgery Association for a paper on prebending rods and sagittal parameters in lumbar degenerative scoliosis. He co-authored Chapter 75 (Lenke-Silva Classification & Adult Degenerative Scoliosis) in The Aging Spine. His thesis analyzed screw malposition in 415 thoracolumbar pedicle fixation cases.
He is a member of the Turkish Neurosurgery Association (Spinal & Peripheral Nerve Surgery Group), the Turkish Spine Association, and the Turkish Medical Association. He completed the Advanced Spinal Surgery Course and the Hands-on Microvascular Anastomosis & Microsurgery training. He holds a Category A Certificate for Experimental Animals. He also attends major spine congresses.
Le médecin est un neurologue très expérimenté, spécialisé dans le diagnostic et le traitement d'un large éventail de troubles neurologiques. Avec plus de 15 ans d'expérience clinique, le médecin a contribué à de nombreuses études de recherche et a été publié dans plusieurs revues médicales prestigieuses. Le médecin a été reconnu pour ses approches innovantes en matière de soins aux patients et a reçu plusieurs prix pour l'excellence en neurologie. De plus, le médecin est certifié par le conseil et participe activement à l'éducation médicale continue pour rester à jour avec les dernières avancées dans le domaine.<\/p>
Dr. Anton Wohl leads the Brain Tumors Unit at Sheba Medical Center (since 2026). He is a neurosurgeon specializing in neuro-oncology, brain tumor surgery, and stereotactic radiosurgery.
He performs complex tumor operations with intraoperative MRI and functional mapping. He also uses fluorescence guidance, neuronavigation, and awake craniotomy to help remove tumors safely and preserve function.
Accreditations: Israeli Board Certification in Neurosurgery; Israeli medical license; advanced international fellowships and training, including the Mayo Clinic (USA).
Research: author and co-author of peer-reviewed publications on glioblastoma, malignant brain tumors, radiosurgery, and experimental therapies.
Éducation
2019
Faculté de médecine d'Istanbul, Electroneurophysiologie
2005
Faculté de médecine, neurologie, Université Cerrahpasa d'Istanbul
1998
Université Cerrahpasa d'Istanbul, Faculté de médecine
Expérience
2017 - 2019
Hôpital privé Adatip Kurtkoy
2016
TND – Prix Schering-Plough des actes de l'année
2015 - 2017
Hôpital privé Gaziosmanpaşa de l'Université Yeni Yüzyıl d'Istanbul
2015 - 2015
Hôpital de formation et de recherche Şişli Hamidiye Etfal
2005 - 2014
Hôpital privé Avicenna Hope
2015 – 2019 Faculté de médecine Cerrahpasa de l'Université d'Istanbul
2019 – Hôpital universitaire Medipol Pendik
Publications
1- Yüz Ağrılarında Trijumeau SEP Uygulaması ; Yüksek Lisans Tezi
2- Glial Tümörlerde P53, PTEN et EGRF Pozitifliğinin İmmunohistokimyasal ; Uzmanlik Tezi
3- Deux frères et sœurs atteints d'homocystinurie présentant une dystonie et un syndrome parkinsonien
4- Absence d'association entre les polymorphismes du gène IL-1ß/? et l'épilepsie du lobe temporal avec sclérose hippocampique
5- Troubles psychogènes du mouvement chez deux enfants
6- Épilepsie du lobe temporel et sclérose hippocampique Hastalarda İnterlökin 1-ß et İnterlökin 1-? Gen Polimorphizminin Analizi
7- Hippocampe Skleroza Bağlı Épilepsie mésiale du lobe temporal ou Interlökin 1-ß et Interlökin 1-? Gen Polimorfizmi İlişkisinin Araştırılması
Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.
He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.
Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.
He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.
He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.
Expérience
2019 – 2019
Faculté de médecine de l'Université d'Insubrie
2015
2013 – 2015
2010 – 2012
2002 – 2003
Éducation
2010
1992
Spécialisation médicale
Université Hacettepe 2017 - 2007
Spécialisation médicale (mineure)
Université d'Ufuk 2011 - 2009
Doctorat
Université d'Ankara 2021 - 2000
Premier cycle
Université d'Ankara 2006
Assistante de recherche
Département de biotechnologie, Institut de biotechnologie, Université d'Ankara
01 septembre 2009 - 08 octobre 2021
Assistante de recherche
Département de pédiatrie, Faculté de médecine, Université Hacettepe
27 février 2014 - 28 février 2017
Assistante de recherche
Dr. Ridvan Ege Centre de recherche et d'application en santé, Université d'Ufuk
27 novembre 2007 - 9 décembre 2011